Fermented Cosmetics and Metabolites of Skin Microbiota—A New Approach to Skin Health
Abstract
:1. Structure of Skin
2. Skin Diseases in the Modern Era
2.1. Eczema Group (Atopic Dermatitis and Contact Dermatitis)
2.2. Skin Cancer (Malignant Tumor)
2.3. Acne (Acne Vulgaris)
3. Types of Indigenous Skin Bacteria and Their Effects on Health
3.1. Indigenous Skin Bacteria
3.2. Distribution of Indigenous Skin Bacteria
3.3. Classification of Skin-Associated Bacteria (Favorable, Hazardous, and Opportunistic Bacteria)
3.4. Health Functionality of Metabolites Produced by Indigenous Bacteria
4. Application of Skin Probiotics in Cosmetics
5. The Japanese Cosmetics Industry and the Growth of Natural Ingredients and Fermented Cosmetics
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Mohammad, Z.A. Skin Tissue Engineering and Regenerative Medicine; Academic Press: Cambridge, MA, USA, 2016; ISBN 978-0-12-801654-1. [Google Scholar]
- Yang, Y.; Qu, L.; Mijakovic, I.; Wei, Y. Advances in the human skin microbiota and its roles in cutaneous diseases. Microb. Cell Factories 2022, 21, 176. [Google Scholar] [CrossRef] [PubMed]
- Mitsui, T. New Cosmetology; Nanzando: Tokyo, Japan, 2009; pp. 13–559. ISBN 978-4-52-578252-8. [Google Scholar]
- Yosshida, T. Forefront of Skin Anti-Aging; NTS: Tokyo, Japan, 2006; pp. 52–54, 62–66. ISBN 4-86043-104-9. [Google Scholar]
- Ozaki, K. Development Industrial Applications of Fermentation Cosmetic Materials; CMC Publishing: Tokyo, Japan, 2020; pp. 12–14. ISBN 978-4-78-131499-0. [Google Scholar]
- Miyazawa, M. Cosmetic Science; Kyoritsu Shuppan: Tokyo, Japan, 2014; pp. 27–32. ISBN 978-4-32-006177-4. [Google Scholar]
- Gordon, R. Skin Cancer: An Overview of Epidemiology and Risk Factors. Semin. Oncol. Nurs. 2013, 29, 160–169. [Google Scholar] [CrossRef] [PubMed]
- Furue, M.; Yamazaki, S.; Jimbow, K.; Tsuchida, T.; Amagai, M.; Tanaka, T. Nationwide cross-sectional and seasonal multicenter study of dermatological patients in Japan. Jpn. J. Dermatol. 2009, 119, 1795–1809. [Google Scholar] [CrossRef]
- Yamamoto, S. Sex and age distribution of some representative dermatoses based upon the five years’ cummulative data. Skin Res. 1981, 23, 197–205. [Google Scholar] [CrossRef]
- Gollnick, H.; Cunliffe, W.; Berson, D.; Dreno, B.; Finlay, A.Y.; Leyden, J.J.; Shalita, A.R.; Thiboutot, D. Management of acne: A report from a global alliance to improve outcomes in acne. J. Am. Acad. Dermatol. 2003, 49, 1–37. [Google Scholar] [CrossRef]
- De Raeve, L.; De Schepper, J.; Smitz, J. Prepubertal acne: A cutaneous marker of androgen excess? J. Am. Acad. Dermatol. 1995, 32, 181–184. [Google Scholar] [CrossRef]
- Byrd, A.L.; Belkaid, Y.; Segre, J.A. The human skin microbiome. Nat. Rev. Microbiol. 2018, 16, 143–155. [Google Scholar] [CrossRef]
- Ohta, T. A peep into invisible community of human indigenous microbes. Jpn. J. Aerosp. Environ. Med. 2012, 49, 37–51. Available online: http://www.sasappa.co.jp/online/abstract/jsasem/1/049/html/1110490301.html (accessed on 15 November 2022).
- Chiller, K.; Selkin, B.A.; Murakawa, G.J. Skin Microflora and Bacterial Infections of the Skin. J. Investig. Dermatol. Symp. Proc. 2001, 6, 170–174. [Google Scholar] [CrossRef] [Green Version]
- Grice, A.E.; Kong, H.H.; Conlan, S.; Deming, C.B.; Davis, J.; Young, A.C.; Bouffard, G.G.; Blakesley, R.W.; Murray, P.R.; Green, E.D.; et al. Topographical and temporal diversity of the human skin microbiome. Science 2009, 324, 1190–1192. [Google Scholar] [CrossRef] [Green Version]
- Evans, A.C.; Smith, W.M.; Johnston, E.A.; Giblett, E.R. Bacterial flora of the normal human skin. J. Investig. Dermatol. 1950, 15, 305–324. [Google Scholar] [CrossRef] [PubMed]
- Nodake, Y.; Matsumoto, S.; Miura, R.; Honda, H.; Ishibashi, G.; Matsumoto, S.; Dekio, I.; Sakakibara, R. Pilot study on novel skin care method by augmentation with S. epidermidis, an autologous skin microbe-A blinded randomized clinical trial. J. Dermatol. Sci. 2015, 79, 119–126. [Google Scholar] [CrossRef] [PubMed]
- Evans, C.A.; Smith, W.M.; Johnston, E.A.; Giblett, E.R. The role of bacteria in the formation of free fatty acids on the human skin surface. J. Investig. Dermatol. 1960, 34, 171–174. [Google Scholar] [CrossRef] [Green Version]
- Lowy, D.F. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339, 520–532. [Google Scholar] [CrossRef]
- Strange, P.; Skov, L.; Lisby, S.; Nielsen, P.L.; Baadsgaard, O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces. J. Arch. Dermatol. 1996, 132, 27–33. [Google Scholar] [CrossRef]
- Baker, B.S. The role of microorganisms in atopic dermatitis. Clin. Exp. Immunol. 2006, 144, 1–9. [Google Scholar] [CrossRef]
- Conwill, A.; Kuan, A.C.; Damerla, R.; Poret, A.J.; Baker, J.S.; Tripp, A.D.; Alm, E.J.; Lieberman, T.D. Anatomy promotes neutral coexistence of strains in the human skin microbiome. Cell Host Microbe 2022, 30, 171–182. [Google Scholar] [CrossRef]
- McGinley, K.J.; Webster, G.F.; Leyden, J.J. Regional variations of cutaneous propionibacteria. Appl. Env. Microbiol. 1978, 35, 62–66. [Google Scholar] [CrossRef] [Green Version]
- Marples, R.R.; Downing, D.T.; Kligman, A.M. Control of Free Fatty Acids in Human Surface Lipids by Corynebacterium Acnes. J. Investig. Dermatol. 1971, 56, 127–131. [Google Scholar] [CrossRef] [Green Version]
- Shu, M.; Wang, Y.; Yu, J.; Kuo, S.; Coda, A.; Jiang, Y.; Gallo, R.L.; Huang, C.-M. Fermentation of Propionibacterium acnes, a Commensal Bacterium in the Human Skin Microbiome, as Skin Probiotics against Methicillin-Resistant Staphylococcus aureus. PLoS ONE 2013, 8, e55380. [Google Scholar] [CrossRef] [Green Version]
- Fluhr, J.W.; Mao-Qiang, M.; Brown, B.E.; Wertz, P.W.; Crumrine, D.; Sundberg, J.P.; Feingold, K.R.; Elias, P.M. Glycerol Regulates Stratum Corneum Hydration in Sebaceous Gland Deficient (Asebia) Mice. J. Investig. Dermatol. 2003, 120, 728–737. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Kuo, S.; Shu, M.; Yu, J.; Huang, S.; Dai, A.; Two, A.; Gallo, R.L.; Huang, C.-M. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: Implications of probiotics in acne vulgaris. Appl. Microbiol. Biotechnol. 2014, 98, 411–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nakamura, K.; O’Neill, A.M.; Williams, M.R.; Cau, L.; Nakatsuji, T.; Horswill, A.R.; Gallo, R.L. Short chain fatty acids produced by Cutibacterium acnes inhibit biofilm formation by Staphylococcus epidermidis. Sci. Rep. 2020, 10, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Moss, C.W.; Dowell, V.R.; Lewis, V.J.; Schekter, M.A. Cultural Characteristics and Fatty Acid Composition of Corynebacterium acnes. J. Bacteriol. 1967, 94, 1300–1305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ryssel, H.; Kloeters, O.; Germann, G.; Schäfer, T.; Wiedemann, G.; Oehlbauer, M. The antimicrobial effect of acetic acid—An alternative to common local antiseptics? Burns 2009, 35, 695–700. [Google Scholar] [CrossRef]
- Keshari, S.; Balasubramaniam, A.; Myagmardoloonjin, B.; Herr, D.R.; Negari, I.P.; Huang, C.-M. Butyric Acid from Probiotic Staphylococcus epidermidis in the Skin Microbiome Down-Regulates the Ultraviolet-Induced Pro-Inflammatory IL-6 Cytokine via Short-Chain Fatty Acid Receptor. Int. J. Mol. Sci. 2019, 20, 4477. [Google Scholar] [CrossRef] [Green Version]
- Kao, M.-S.; Huang, S.; Chang, W.-L.; Hsieh, M.-F.; Huang, C.-J.; Gallo, R.L. Microbiome precision editing: Using PEG as a selective fermentation initiator against methicillin-resistant Staphylococcus aureus. Biotechnol. J. 2017, 12. [Google Scholar] [CrossRef] [Green Version]
- Heim, C.E.; Bosch, M.E.; Yamada, K.J.; Aldrich, A.L.; Chaudhari, S.S.; Klinkebiel, D.; Gries, C.M.; Alqarzaee, A.A.; Li, Y.; Thomas, V.C.; et al. Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection. Nat. Microbiol. 2020, 5, 1271–1284. [Google Scholar] [CrossRef]
- Sugawara, T.; Kikuchi, K.; Tagami, H.; Aiba, S.; Sakai, S. Decreased lactate and potassium levels in natural moisturizing factor from the stratum corneum of mild atopic dermatitis patients are involved with the reduced hydration state. J. Dermatol. Sci. 2012, 66, 154–159. [Google Scholar] [CrossRef]
- Desbois, A.P.; Smith, V.J. Antibacterial free fatty acids: Activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 2009, 85, 1629–1642. [Google Scholar] [CrossRef] [Green Version]
- Rfeef, A. University of Southampton Research Repository. Doctoral Thesis, University of Southampton, Southampton, UK, 2020; p. 173. Available online: https://eprints.soton.ac.uk/437367/1/eThesis_DiogoGoncalvesdaSilva_September2019.pdf (accessed on 15 November 2022).
- Manisha, N. The use of topical Nitrosomonas eutropha for cosmetic improvement of facial wrinkles. J. Cosmet. Dermatol. 2020, 19, 689–693. [Google Scholar] [CrossRef]
- Yejin, L. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes. J. Biotechnol. 2008, 18, 1308–1316. [Google Scholar]
- Audrey, G. Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract. Eur. J. Dermatol. 2006, 16, 380–384. [Google Scholar]
- Gueniche, A.; Valois, A.; Kerob, D.; Rasmont, V.; Nielsen, M. A combination of Vitreoscilla filiformis extract and Vichy volcanic mineralizing water strengthens the skin defenses and skin barrier. J. Eur. Acad. Dermatol. Venereol. 2022, 36 (Suppl. S2), 16–25. [Google Scholar] [CrossRef]
- Seite, S.; Zelenkova, H.; Martin, R. Clinical efficacy of emollients in atopic dermatitis patients–relationship with the skin microbiota modification. Clin. Cosmet. Investig. Dermatol. 2017, ume 10, 25–33. [Google Scholar] [CrossRef] [Green Version]
- Dimarzio, L.; Cinque, B.; Cupelli, F.; De Simone, C.; Cifone, M.G.; Giuliani, M. Increase of Skin-Ceramide Levels in Aged Subjects following a Short-Term Topical Application of Bacterial Sphingomyelinase from Streptococcus Thermophilus. Int. J. Immunopathol. Pharmacol. 2008, 21, 137–143. [Google Scholar] [CrossRef] [PubMed]
- Di Marzio, L.; Centi, C.; Cinque, B.; Masci, S.; Giuliani, M.; Arcieri, A.; Zicari, L.; De Simone, C.; Cifone, M.G. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp. Dermatol. 2003, 12, 615–620. [Google Scholar] [CrossRef]
- Kim, W.-K.; Jang, Y.J.; Han, D.H.; Jeon, K.; Lee, C.; Han, H.S.; Ko, G. Lactobacillus paracasei KBL382 administration attenuates atopic dermatitis by modulating immune response and gut microbiota. Gut Microbes 2020, 12, e1819156. [Google Scholar] [CrossRef] [PubMed]
- Jung, E. Fermentation product with new equol-producing Lactobacillus paracasei as a probiotic-like product candidate for prevention of skin and intestinal disorder. J. Sci. Food Agric. 2019, 99, 4200–4210. [Google Scholar] [CrossRef]
- Miyaguchi, E. Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J. Dairy Sci. 2009, 92, 2400–2408. [Google Scholar] [CrossRef] [Green Version]
- Jung, Y. Lysates of a probiotic, Lactobacillus rhamnosus, can improve skin barrier function in a reconstructed human epidermis model. Int. J. Mol. Sci. 2019, 20, 4289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, N. Enhancement of skin whitening and anti-wrinkle activities of the co-culture of Lactobacillus rhamnosus and Lactobacillus paracasei. J. Soc. Cosmet. Sci. Korea 2015, 41, 253–261. [Google Scholar] [CrossRef] [Green Version]
- Tokudome, Y. Influence of oral administration of lactic acid bacteria metabolites on skin barrier function and water content in a murine model of atopic ermatitis. Nutrients 2018, 10, 1858. [Google Scholar] [CrossRef]
- Otsuka, M.; Tamane, T.; Tokudome, Y. Effect of lactic fermentation products on human epidermal cell differentiation, ceramide content, and amino acid production. Skin Pharmacol. Physiol. 2021, 34, 103–113. [Google Scholar] [CrossRef]
- Kitagaki, H.; Kitamoto, K. Breeding Research on Sake Yeasts in Japan: History, Recent Technological Advances, and Future Perspectives. Annu. Rev. Food Sci. Technol. 2013, 4, 215–235. [Google Scholar] [CrossRef] [PubMed]
- Kitagaki, H. Medical application of substances derived from non-pathogenic fungi Aspergillus oryzae and A. luchuensis-containing koji. J. Fungi. 2021, 7, 243. [Google Scholar] [CrossRef]
- Takahashi, K.; Izumi, K.; Nakahata, E.; Hirata, M.; Sawada, K.; Tsuge, K.; Nagao, K.; Kitagaki, H. Quantitation and Structural Determination of Glucosylceramides Contained in Sake Lees. J. Oleo Sci. 2014, 63, 15–23. [Google Scholar] [CrossRef] [Green Version]
- Hirata, M.; Tsuge, K.; Jayakody, L.N.; Urano, Y.; Sawada, K.; Inaba, S.; Nagao, K.; Kitagaki, H. Structural Determination of Glucosylceramides in the Distillation Remnants of Shochu, the Japanese Traditional Liquor, and Its Production by Aspergillus kawachii. J. Agric. Food Chem. 2012, 60, 11473–11482. [Google Scholar] [CrossRef]
- Jeon, H.J.; Noda, M.; Maruyama, M.; Matoba, Y.; Kumagai, A.T.; Sugiyama, M. Identification and Kinetic Study of Tyrosinase Inhibitors Found in Sake Lees. J. Agric. Food Chem. 2006, 54, 9827–9833. [Google Scholar] [CrossRef]
- Miyagawa, M.; Fujikawa, A.; Nagadome, M.; Kohama, K.; Ogami, T.; Kitamura, S.; Kitagaki, H. Glycosylceramides Purified from the Japanese Traditional Non-Pathogenic Fungus Aspergillus and Koji Increase the Expression of Genes Involved in Tight Junctions and Ceramide Delivery in Normal Human Epidermal Keratinocytes. Fermentation 2019, 5, 43. [Google Scholar] [CrossRef] [Green Version]
- Kikuchi-Hayakawa, H.; Onodera, N.; Matsubara, S.; Yasuda, E.; Chonan, O.; Takahashi, R.; Ishikawa, F. Effects of Soy Milk and Bifidobacterium Fermented Soy Milk on Lipid Metabolism in Aged Ovariectomized Rats. Biosci. Biotechnol. Biochem. 1998, 62, 1688–1692. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bogaki, T.; Mitani, K.; Oura, Y.; Ozeki, K. Effects of ethyl-α-d-glucoside on human dermal fibroblasts. Biosci. Biotechnol. Biochem. 2017, 81, 1706–1711. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Otsuka, A.; Moriguchi, C.; Shigematsu, Y.; Tanabe, K.; Haraguchi, N.; Iwashita, S.; Tokudome, Y.; Kitagaki, H. Fermented Cosmetics and Metabolites of Skin Microbiota—A New Approach to Skin Health. Fermentation 2022, 8, 703. https://doi.org/10.3390/fermentation8120703
Otsuka A, Moriguchi C, Shigematsu Y, Tanabe K, Haraguchi N, Iwashita S, Tokudome Y, Kitagaki H. Fermented Cosmetics and Metabolites of Skin Microbiota—A New Approach to Skin Health. Fermentation. 2022; 8(12):703. https://doi.org/10.3390/fermentation8120703
Chicago/Turabian StyleOtsuka, Akira, Chihiro Moriguchi, Yuka Shigematsu, Kurumi Tanabe, Nanami Haraguchi, Sonoko Iwashita, Yoshihiro Tokudome, and Hiroshi Kitagaki. 2022. "Fermented Cosmetics and Metabolites of Skin Microbiota—A New Approach to Skin Health" Fermentation 8, no. 12: 703. https://doi.org/10.3390/fermentation8120703
APA StyleOtsuka, A., Moriguchi, C., Shigematsu, Y., Tanabe, K., Haraguchi, N., Iwashita, S., Tokudome, Y., & Kitagaki, H. (2022). Fermented Cosmetics and Metabolites of Skin Microbiota—A New Approach to Skin Health. Fermentation, 8(12), 703. https://doi.org/10.3390/fermentation8120703